<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Cell and Developmental Biology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/414D6059-7ED1-4FAE-986D-FFE89883FFC2"><gtr:id>414D6059-7ED1-4FAE-986D-FFE89883FFC2</gtr:id><gtr:firstName>Sanjay</gtr:firstName><gtr:surname>Sisodiya</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B502872D-53F9-42EB-8D1E-45D7522C3D98"><gtr:id>B502872D-53F9-42EB-8D1E-45D7522C3D98</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3AF338C5-29C8-4764-96B5-61846F13F152"><gtr:id>3AF338C5-29C8-4764-96B5-61846F13F152</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Goldstein</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/201636C4-A28A-45C9-B123-C1341019BBA0"><gtr:id>201636C4-A28A-45C9-B123-C1341019BBA0</gtr:id><gtr:firstName>Elizabeth</gtr:firstName><gtr:surname>Fisher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400017"><gtr:id>9784E2D4-5771-4177-A4F4-E144A4728C3B</gtr:id><gtr:title>Population genetic analyses of neuronal disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400017</gtr:grantReference><gtr:abstractText>The members of this grouping are all committed to the communication of their work to the broadest possible audience. In addition to communicating their work through the scientific press, members of the grouping also inform relevant disease-oriented societies through newsletters and lectures. Members of the group also regularly provide commentary on advances in human and medical genetics to newspapers, radio shows, and documentaries. The co-operative grouping will allow us to form a focal point for dissemination of information specifically related to neurogenetics. One of our key aims will be to accurately convey both the strengths and the limitations of what we know about how genetic variation influences health and disease. In addition, the grouping will continue and expand its efforts to advise both policy makers and ethics groups about developments in human genetics, as for example we have done in the past in pharmacogenetics and other areas.</gtr:abstractText><gtr:technicalSummary>This core application will establish a common experimental and analytic framework for a series of investigations into the genetic bases of three important neuronal diseases: Amyotrophic Lateral Sclerosis, Parkinson?s disease, and epilepsy. The focus of the application will be genetic association studies seeking to correlate gene variants in candidate genes both with disease status, and with more detailed clinical characteristics of the disease (e.g. age of onset, severity, response to treatment, and so on). The proposal unites exceptional clinical resources and a team of researchers with both clinical and genetics expertise with a proven track record of collaboration. The core will focus on statistical genetics and bioinformatics, and quality control of genotyping, while the component projects of the grouping will focus on patient recruitment and phenotyping. All members of the grouping however will interact regularly to ensure that the design and interpretation of the genetic analyses is fully informed by the pathophysiology of the relevant conditions. The grouping will establish a critical mass of researchers with similar interests and aims, which will mean that common challenges can be identified and overcome.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>180969</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Mitochondrial Research Group</gtr:department><gtr:description>Wellcome Trust Case-Control consortium</gtr:description><gtr:id>EE8AE572-5352-48A8-A78F-FF051CEA348B</gtr:id><gtr:impact>Puclications which have been listed.</gtr:impact><gtr:outcomeId>Pei1XGzGxX4-4</gtr:outcomeId><gtr:partnerContribution>Input of ideas/expertise to enable successful grant applications and publicationsClinical samples and cognitive data in PD patientsHomozygosity analysis in PD and preliminary analysis of age at onset and cognitive phenotypes in PDInput of ideas/expertise to enable successful grant applications and publications</gtr:partnerContribution><gtr:piContribution>Contributed well characterised clinical cases and DNA samples for large scale genetic studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Neurosciences</gtr:department><gtr:description>Wellcome Trust Case-Control consortium</gtr:description><gtr:id>87BD9C35-1969-4C45-B015-3ABD14629F70</gtr:id><gtr:impact>Puclications which have been listed.</gtr:impact><gtr:outcomeId>Pei1XGzGxX4-2</gtr:outcomeId><gtr:partnerContribution>Input of ideas/expertise to enable successful grant applications and publicationsClinical samples and cognitive data in PD patientsHomozygosity analysis in PD and preliminary analysis of age at onset and cognitive phenotypes in PDInput of ideas/expertise to enable successful grant applications and publications</gtr:partnerContribution><gtr:piContribution>Contributed well characterised clinical cases and DNA samples for large scale genetic studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>Wellcome Trust Case-Control consortium</gtr:description><gtr:id>C7F7BB79-4886-48B0-9D41-CF8550148A02</gtr:id><gtr:impact>Puclications which have been listed.</gtr:impact><gtr:outcomeId>Pei1XGzGxX4-1</gtr:outcomeId><gtr:partnerContribution>Input of ideas/expertise to enable successful grant applications and publicationsClinical samples and cognitive data in PD patientsHomozygosity analysis in PD and preliminary analysis of age at onset and cognitive phenotypes in PDInput of ideas/expertise to enable successful grant applications and publications</gtr:partnerContribution><gtr:piContribution>Contributed well characterised clinical cases and DNA samples for large scale genetic studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Psychological Medicine and Clinical Neurosciences</gtr:department><gtr:description>Wellcome Trust Case-Control consortium</gtr:description><gtr:id>46EB5FC1-5FAE-42FC-82F0-4229E836849E</gtr:id><gtr:impact>Puclications which have been listed.</gtr:impact><gtr:outcomeId>Pei1XGzGxX4-3</gtr:outcomeId><gtr:partnerContribution>Input of ideas/expertise to enable successful grant applications and publicationsClinical samples and cognitive data in PD patientsHomozygosity analysis in PD and preliminary analysis of age at onset and cognitive phenotypes in PDInput of ideas/expertise to enable successful grant applications and publications</gtr:partnerContribution><gtr:piContribution>Contributed well characterised clinical cases and DNA samples for large scale genetic studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>292590</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>FF551D10-4209-45C8-B35B-CD723FF74E6B</gtr:id><gtr:outcomeId>jJwaxSR4Yfw0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigator Award</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>8B7B2F67-1B54-4E3F-A2D4-6442D36FF5AB</gtr:id><gtr:outcomeId>Nw2ndd7Fyd40</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>129110</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Fellowship</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7666AA75-6447-4061-9F32-F68938C9BF7B</gtr:id><gtr:outcomeId>JSRU6LGtTfA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>315000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>B7BF9169-57C5-4245-A1F3-295BB997FAF2</gtr:id><gtr:outcomeId>nLLiJU4j1bo0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>661636</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Infrastructure Award</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9642FA31-4903-421A-901E-C05AD270334D</gtr:id><gtr:outcomeId>S96VBm896FJ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WTCCC2- Parkinson's disease</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>051EF2D5-D402-4157-A3A0-A0771A0D71C0</gtr:id><gtr:outcomeId>57C603534B10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WTCCC2- Epilepsy</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>B82B2F1A-1C28-4D3C-8CFD-1DBEC11C5857</gtr:id><gtr:outcomeId>007BC70E3170</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>339000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment Grant</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>81207C3A-E72F-4076-A14B-94CA6F03BC03</gtr:id><gtr:outcomeId>RgGTvs9G4bV0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F3C3AD84-5D86-4DF6-A286-FD49217FA084</gtr:id><gtr:title>Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cc40dfc64d4f648f783ef445045a4ff"><gtr:id>5cc40dfc64d4f648f783ef445045a4ff</gtr:id><gtr:otherNames>Heinzen EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>84D3CE5AC51</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDCC3A5A-F594-45DC-96CF-B59BC463A1E1</gtr:id><gtr:title>Examining the role of common genetic variation in the gamma2 subunit of the GABA(A) receptor in epilepsy using tagging SNPs.</gtr:title><gtr:parentPublicationTitle>Epilepsy research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19d12c7281c5892e03b4c493d3d93ca3"><gtr:id>19d12c7281c5892e03b4c493d3d93ca3</gtr:id><gtr:otherNames>Kinirons P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0920-1211</gtr:issn><gtr:outcomeId>96E03307871</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59A4371A-2F01-42CE-A7CD-92FC8730F408</gtr:id><gtr:title>A two-stage meta-analysis identifies several new loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21954146dfa6bdef021f2fa27d03fd93"><gtr:id>21954146dfa6bdef021f2fa27d03fd93</gtr:id><gtr:otherNames>International Parkinson's Disease Genomics Consortium (IPDGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>Jndfnry7TvN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>907DB6D8-9E31-4233-9122-6EDD66654AFB</gtr:id><gtr:title>Large-scale pathways-based association study in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1bc530dea0f047a0508cb343a8ec2de"><gtr:id>c1bc530dea0f047a0508cb343a8ec2de</gtr:id><gtr:otherNames>Kasperaviciute D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>C9827481FAE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>055BF4B7-0C3E-4E45-93F7-F162CF211859</gtr:id><gtr:title>Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737a3b1b4bbcc2863da782c70d702de5"><gtr:id>737a3b1b4bbcc2863da782c70d702de5</gtr:id><gtr:otherNames>Vandrovcova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>3D01B8534E8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A48D8C71-4C99-49F2-A4A8-E247B20F3D75</gtr:id><gtr:title>Genetic association studies of complex neurological diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f333a28718255f499b4e4420ba5c884"><gtr:id>7f333a28718255f499b4e4420ba5c884</gtr:id><gtr:otherNames>Abou-Sleiman PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>645C947E4B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1B5AA3C-37D8-4FDD-B6B0-C96DB270226E</gtr:id><gtr:title>Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab4100a94e73c7e209657db411c2d9f1"><gtr:id>ab4100a94e73c7e209657db411c2d9f1</gtr:id><gtr:otherNames>International Multiple Sclerosis Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>HRrFWhazn6G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B3975F6-E1C3-4D88-81EA-600769348D2E</gtr:id><gtr:title>Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7bc8538c82db76d6e2482ddeeb2d3d0"><gtr:id>d7bc8538c82db76d6e2482ddeeb2d3d0</gtr:id><gtr:otherNames>Al-Chalabi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>512257716C9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EBD2D1D-B3BA-41B3-9C8C-4CAD6401B7BB</gtr:id><gtr:title>Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e2d0f395414b93ca8e16b698d9d8d12"><gtr:id>1e2d0f395414b93ca8e16b698d9d8d12</gtr:id><gtr:otherNames>International Parkinson Disease Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>hc8ZYWiFDGX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>625861BC-C306-4B0D-8FAF-5DFD5D29BF5B</gtr:id><gtr:title>A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7204e0994584ae87d35d658678945308"><gtr:id>7204e0994584ae87d35d658678945308</gtr:id><gtr:otherNames>Cavalleri GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>FFB4637D6CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC045A6C-9E88-4E28-B905-4BF70DE0ABAB</gtr:id><gtr:title>Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cc40dfc64d4f648f783ef445045a4ff"><gtr:id>5cc40dfc64d4f648f783ef445045a4ff</gtr:id><gtr:otherNames>Heinzen EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>2A6841B0BF4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A314F83B-A31B-4CCD-BA18-DDED30A8621E</gtr:id><gtr:title>NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f59a922685f5199fdfb53d3100807996"><gtr:id>f59a922685f5199fdfb53d3100807996</gtr:id><gtr:otherNames>Healy DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>E73AB6A4C4D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50803C27-EDBB-4D34-815F-7DB6C5E0806B</gtr:id><gtr:title>Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7204e0994584ae87d35d658678945308"><gtr:id>7204e0994584ae87d35d658678945308</gtr:id><gtr:otherNames>Cavalleri GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>6F296CE7605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81168B17-FF03-4A9C-A95B-EC47EFEAE432</gtr:id><gtr:title>No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.</gtr:title><gtr:parentPublicationTitle>Epilepsy research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39b64d3ef3b2a06841d419dc7fa8db61"><gtr:id>39b64d3ef3b2a06841d419dc7fa8db61</gtr:id><gtr:otherNames>Lynch JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0920-1211</gtr:issn><gtr:outcomeId>D8A19CF616C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE943BD1-EC6A-48CB-95BB-D35E6379AFEB</gtr:id><gtr:title>Parkinson's disease and cancer: two wars, one front.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81b016b620411b3da51cfd468ebe3c2a"><gtr:id>81b016b620411b3da51cfd468ebe3c2a</gtr:id><gtr:otherNames>Devine MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-175X</gtr:issn><gtr:outcomeId>EVsnYuAbqqV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BD4CE41-9E09-471C-AF51-0D44D07A82FF</gtr:id><gtr:title>Test for LRRK2 mutations in patients with Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f59a922685f5199fdfb53d3100807996"><gtr:id>f59a922685f5199fdfb53d3100807996</gtr:id><gtr:otherNames>Healy DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>29935DE68CF</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400017</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>